Job Description

The Vice President, Oncology Asset Team is responsible and accountable for the end-to-end lifecycle management for our company's late-stage multi-tumor assets. This includes the breadth/depth of development across different disease TA sections, timing of studies across Disease Therapeutic Areas (TA) and timing of launches. The Vice President (VP) will work collaboratively with Oncology VP TA heads directly as well as through the interaction of Asset Teams and Disease Specific Product Development Teams (PDT) to evaluate potential indications in specific disease areas.

This individual will ensure effective and seamless cross functional collaboration of the ADTs with the respective Early-Stage Development teams (EDT) and PDTs by establishing credibility, securing appropriate sponsorship, establishing clarity of roles & responsibilities, effective decision making, and driving a culture of mutual respect across ADT and EDT/PDT teams.

The TA teams will make recommendations to the ADT regarding potential studies and development strategies for specific disease(s). TAs and PDTs (Tumor Teams) will be responsible for the conduct of agreed-upon tumor-specific Umbrella, Phase 2 and Phase 3 studies.

ADTs will be responsible for conducting or working with Translational Medicine to conduct clinical pharmacology studies (e.g. food effect, DDI, TQT, etc), as well as basket studies of an asset across multiple tumors. The AT will be responsible and accountable for ensuring consistency of asset related issues across TAs.

ADTs will work collaboratively across our company to ensure cross functional needs are met including CMC, Medical, Commercial Planning, Launch Sequencing, Access and other lifecycle management activities including IBs, DSURs, and other asset specific activities.

Primary Responsibilities:

• Responsible for broad strategic oversight and life-cycle management of individual assets with multi-disease area potential.

• Works with the TA heads to consider disease area prioritizations and how disease area priorities for an asset matrix with the individual asset prioritizations.

• Manages a group of Asset Team Leads who will develop individual molecule late-stage development plans; will work across TA areas to gain insights /expert advice regarding tumor specific development; will design and conduct basket studies for assets; will work with Early Oncology to advance biomarker strategies and ensures continuity of asset knowledge / strategies across PDTs.

• Empowers Asset Teams to develop Asset level strategy that can quickly respond to changing priorities and portfolio needs.

• Empowers Asset Teams that considers the full E2E development requirements and enables cross-Tumor Team execution and successful approval of the product.

• Ensures clinical programs and clinical studies are designed and monitored optimally. Ensures that clinical documents are of highest quality.

• Interfaces with functional leaders within Research & Development (e.g., Discovery, Translational Biomarkers, GCTO, BARDS, GRACS, TPharm), CORE, GHH, and Manufacturing to ensure optimal decision-making and operational excellence in the leadership of Integration Teams.

• Lead the effective translation of prioritization into resourcing needs across the ATs.

• Ensures membership of ATs reflect the need of the relevant product and are adequately resourced to support independent decision making.

• Leads the decision making on timing of establishing new ATs, considering when multiple registrational-intent tumor strategies are anticipated

• The Asset Team VP will manage individuals who lead multi-tumor asset teams (asset team leads). Any clinical development staff reporting to the ATL will be indirect reports.

Education:

• M.D or M.D./Ph.D.

• Ph.D. and/or Pharm.D candidates with more than 10 years of relevant industry experience

• Extensive knowledge of the oncology therapeutic area

Required Experience and Skills:

• Strong expertise in medical and translational sciences, clinical and predictive biomarker development, medical program design through all phases of clinical development

• Understands and demonstrates ownership of the commercialization of products through the pipeline

• Strong credibility in the scientific community, internally and externally, along with the ability to represent the company externally

• Multiple/varied experiences bringing a product through all cycles of development, including achieving product licensure with or without a companion or complementary predictive biomarker

• Proven ability in creating, driving and aligning global medical strategies with corporate goals and providing critical therapeutic area insights

• Management experience in a clinical development setting

• Proven ability to lead a high performance cross-functional teams (e.g. EDT/PDTs or similar)

• Strong interpersonal skills and executive presence to successfully engage senior leaders in governance meetings

Current Employees apply HERE

Current Contingent Workers apply HERE

US and Puerto Rico Residents Only:

Our company is committed to inclusion, ensuring that candidates can engage in a hiring process that exhibits their true capabilities. Please click here if you need an accommodation during the application or hiring process.

As an Equal Employment Opportunity Employer, we provide equal opportunities to all employees and applicants for employment and prohibit discrimination on the basis of race, color, age, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability status, or other applicable legally protected characteristics. As a federal contractor, we comply with all affirmative action requirements for protected veterans and individuals with disabilities. For more information about personal rights under the U.S. Equal Opportunity Employment laws, visit:

EEOC Know Your Rights

EEOC GINA Supplement

We are proud to be a company that embraces the value of bringing together, talented, and committed people with diverse experiences, perspectives, skills and backgrounds. The fastest way to breakthrough innovation is when people with diverse ideas, broad experiences, backgrounds, and skills come together in an inclusive environment. We encourage our colleagues to respectfully challenge one another’s thinking and approach problems collectively.

Learn more about your rights, including under California, Colorado and other US State Acts

U.S. Hybrid Work Model

Effective September 5, 2023, employees in office-based positions in the U.S. will be working a Hybrid work consisting of three total days on-site per week, Monday - Thursday, although the specific days may vary by site or organization, with Friday designated as a remote-working day, unless business critical tasks require an on-site presence.This Hybrid work model does not apply to, and daily in-person attendance is required for, field-based positions; facility-based, manufacturing-based, or research-based positions where the work to be performed is located at a Company site; positions covered by a collective-bargaining agreement (unless the agreement provides for hybrid work); or any other position for which the Company has determined the job requirements cannot be reasonably met working remotely. Please note, this Hybrid work model guidance also does not apply to roles that have been designated as “remote”.

The Company is required to provide a reasonable estimate of the salary range for this job in certain states and cities within the United States. Final determinations with respect to salary will take into account a number of factors, which may include, but not be limited to the primary work location and the chosen candidate’s relevant skills, experience, and education.

Expected US salary range:

$408,600.00 - $643,200.00

Available benefits include bonus eligibility, long term incentive if applicable, health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and sick days. A summary of benefits is listed here.

San Francisco Residents Only: We will consider qualified applicants with arrest and conviction records for employment in compliance with the San Francisco Fair Chance Ordinance

Los Angeles Residents Only: We will consider for employment all qualified applicants, including those with criminal histories, in a manner consistent with the requirements of applicable state and local laws, including the City of Los Angeles’ Fair Chance Initiative for Hiring Ordinance

Search Firm Representatives Please Read Carefully
Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, no phone calls or emails.

Employee Status:

Regular

Relocation:

VISA Sponsorship:

Travel Requirements:

Flexible Work Arrangements:

Hybrid

Shift:

Valid Driving License:

Hazardous Material(s):

Job Posting End Date:

06/2/2025

*A job posting is effective until 11:59:59PM on the day BEFORE the listed job posting end date. Please ensure you apply to a job posting no later than the day BEFORE the job posting end date.